Futura Medical plc (FRA:GYX)

Market Cap	9.23M -73.4%
Revenue (ttm)	9.25M -5.6%
Net Income	-7.34M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5,108
Open	0.0110
Previous Close	0.0120
Day's Range	0.0110 - 0.0110
52-Week Range	0.0040 - 0.1750
Beta	n/a
RSI	53.37
Earnings Date	Apr 29, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GYX

Financial Performance

Financial numbers in GBP